The Food and Drug Administration (FDA)Â is alerting hospitals, healthcare providers, veterinarians, and patients of a voluntary recall of certain human and veterinary products produced and distributed for sterile use by Specialty Medicine Compounding Pharmacy of South Lyon, Mich.
Â
According to information provided by Specialty Medicine Compounding Pharmacy, the recalled products were distributed directly to hospitals and patients located in the state of Michigan between July 1, 2013 and Oct. 19, 2013. No products were distributed outside of the state, according to the firm.
Â
The recall is being initiated by Specialty Medicine Compounding Pharmacy after unidentified particulate matter was found floating in a sterile product from the same lot as products that may have been administered to patients at a Michigan hospital.
Â
At this time the FDA recommends that any sterile product produced by Specialty Medicine Compounding Pharmacy should not be used or administered to patients or animals. Hospitals, healthcare providers, veterinarians, and patients who have received any sterile product produced by Specialty Medicine Compounding Pharmacy should immediately discontinue use, quarantine all sterile products, and return the recalled products to Specialty Medicine Compounding Pharmacy.
Â
For additional details about the recall, contact Specialty Medicine Compounding Pharmacy at (248) 446-2643.
Â
At this time the FDA says it is not aware of any adverse events associated with Specialty Medicine Compoundings products. The FDA is working closely with the Centers for Disease Control and Prevention and Michigan state officials to determine the scope of the contamination. The agencys investigation is ongoing.
Â
Patient safety is a top priority for the agency, and giving a patient a contaminated injectable drug could result in a life-threatening infection, says Howard Sklamberg, director of the Office of Compliance in the FDAs Center for Drug Evaluation and Research. Out of an abundance of caution, we are recommending that patients discontinue use of any sterile product produced by this firm.
Source: FDA
I Was There: An Infection Preventionist on the COVID-19 Pandemic
April 30th 2025Deep feelings run strong about the COVID-19 pandemic, and some beautiful art has come out of those emotions. Infection Control Today is proud to share this poem by Carmen Duke, MPH, CIC, in response to a recent article by Heather Stoltzfus, MPH, RN, CIC.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.